Come up with a name for your new list and we'll add to it:
Polyphor raised a round of funding on , . Investors include
Novartis Venture Funds.
Polyphor is a clinical-stage Swiss specialty pharma company focused on the development of macrocycle drugs addressing antibiotic resistance and respiratory diseases. The company's lead drug candidates…